Washington, DC - Today the FDA announced the availability of a revised final guidance: “Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components.” This revised guidance replaces the August 2016 guidance, which recommended universal nucleic acid testing for Zika virus of individual units of blood donated in the U.S. states and territories. The revised guidance explains that, in order to comply with applicable testing regulations, blood establishments must continue to test all donated Whole Blood and blood components for Zika virus using a nucleic acid test.

Washington, DC - A new study from the U.S. Department of Agriculture shows that when it comes to handwashing before meals, consumers are failing to properly clean their hands 97 percent of the time. Rushed handwashing can lead to cross-contamination of food and other surfaces, resulting in foodborne illness.

Arlington, Virginia - The American Heart Association (AHA) and the American Diabetes Association (ADA) today announced the start of a new multi-year collaborative initiative supported by founding sponsors Boehringer Ingelheim, Eli Lilly and Company (Lilly), and Novo Nordisk. The initiative’s goal is to help people with type 2 diabetes reduce their risk of disability and death due to cardiovascular events such as heart attack and stroke. Additional support for the initiative is provided by national sponsor, Sanofi.

West Lafayette, Indiana - A multidisciplinary team of researchers at Purdue University and the University of Bordeaux in France has received a grant from The Michael J. Fox Foundation for Parkinson’s Disease to study a new gene associated with Parkinson’s disease, which was linked to the disease using novel big data methodologies.

Washington, DC - The National Institutes of Health has formed the Trans-NIH Pediatric Research Consortium to coordinate pediatric research programs across its institutes and centers. Nearly all of the 27 NIH institutes and centers fund some aspects of child health research.

Washington, DC - Monday, the Department of Health and Human Services (HHS) released information on how States can cover the cost of treating babies suffering from neonatal abstinence syndrome (NAS).  NAS occurs when babies are exposed to opioids or other addictive drugs during pregnancy, and then experience painful withdrawal symptoms during their first few weeks of life.